Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Praxis Precision Medicines (PRAX) FCF Margin (2023 - 2024)

Historic FCF Margin for Praxis Precision Medicines (PRAX) over the last 2 years, with Q4 2024 value amounting to 752.0%.

  • Praxis Precision Medicines' FCF Margin rose 38812000.0% to 752.0% in Q4 2024 from the same period last year, while for Sep 2025 it was 3067.41%, marking a year-over-year increase of 31317200.0%. This contributed to the annual value of 1540.48% for FY2024, which is 30032900.0% up from last year.
  • Praxis Precision Medicines' FCF Margin amounted to 752.0% in Q4 2024, which was up 38812000.0% from 9105.96% recorded in Q3 2024.
  • In the past 5 years, Praxis Precision Medicines' FCF Margin ranged from a high of 752.0% in Q4 2024 and a low of 9105.96% during Q3 2024